Literature DB >> 29266591

Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease.

Catherine Lee1, Rebecca A Betensky1.   

Abstract

Relating time-varying biomarkers of Alzheimer's disease to time-to-event using a Cox model is complicated by the fact that Alzheimer's disease biomarkers are sparsely collected, typically only at study entry; this is problematic since Cox regression with time-varying covariates requires observation of the covariate process at all failure times. The analysis might be simplified by using study entry as the time origin and treating the time-varying covariate measured at study entry as a fixed baseline covariate. In this paper, we first derive conditions under which using an incorrect time origin of study entry results in consistent estimation of regression parameters when the time-varying covariate is continuous and fully observed. We then derive conditions under which treating the time-varying covariate as fixed at study entry results in consistent estimation. We provide methods for estimating the regression parameter when a functional form can be assumed for the time-varying biomarker, which is measured only at study entry. We demonstrate our analytical results in a simulation study and apply our methods to data from the Rush Religious Orders Study and Memory and Aging Project and data from the Alzheimer's Disease Neuroimaging Initiative.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Cox model; delayed entry; left truncation; survival analysis; time origin; time-dependent covariates

Mesh:

Substances:

Year:  2017        PMID: 29266591      PMCID: PMC5801265          DOI: 10.1002/sim.7547

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Survival analysis in natural history studies of disease.

Authors:  N Keiding; M W Knuiman
Journal:  Stat Med       Date:  1990-10       Impact factor: 2.373

2.  Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study.

Authors:  Anne C M Thiébaut; Jacques Bénichou
Journal:  Stat Med       Date:  2004-12-30       Impact factor: 2.373

3.  Choice of time scale and its effect on significance of predictors in longitudinal studies.

Authors:  Michael J Pencina; Martin G Larson; Ralph B D'Agostino
Journal:  Stat Med       Date:  2007-03-15       Impact factor: 2.373

4.  What time is it? Choice of time origin and scale in extended proportional hazards models.

Authors:  John Fieberg; Glenn D DelGiudice
Journal:  Ecology       Date:  2009-06       Impact factor: 5.499

5.  Re: "Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale".

Authors:  D D Ingram; D M Makuc; J J Feldman
Journal:  Am J Epidemiol       Date:  1997-09-15       Impact factor: 4.897

6.  A joint model for survival and longitudinal data measured with error.

Authors:  M S Wulfsohn; A A Tsiatis
Journal:  Biometrics       Date:  1997-03       Impact factor: 2.571

7.  Overview and findings from the rush Memory and Aging Project.

Authors:  David A Bennett; Julie A Schneider; Aron S Buchman; Lisa L Barnes; Patricia A Boyle; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

8.  Survival analysis in natural history studies of disease.

Authors:  A Cnaan; L Ryan
Journal:  Stat Med       Date:  1989-10       Impact factor: 2.373

9.  Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Authors:  Susanne G Mueller; Michael W Weiner; Leon J Thal; Ronald C Petersen; Clifford R Jack; William Jagust; John Q Trojanowski; Arthur W Toga; Laurel Beckett
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

10.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.